Biotechnology NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales July 13, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AXSM, APPS and YEXT July 12, 2022
Biotechnology FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the Firm July 12, 2022
Biotechnology CLASS ACTION UPDATE for AXSM, APPS and U: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders July 12, 2022
Search
Biotechnology
